medical affair

1. Aspiris Cerebris: April- Oct 2022
A. Medico Marketing Activity B. KOL Support and
Engagement
C. Long Term Growth Plan D. Clinical Trial E. Training and
Development
F. Medical Affairs
Training & Development
G. Corporate Meetings
A.1 New Product Launch/
Brand Promotion
Launch PPT
1. KOL Interactions 1. New Product Evaluation
(BU / BD)
1. PMS (Phase 4 Study) 1. Sales Team: Managers 1. Med. Affairs Daily Calls
(Mon – Wed – Fri)
1. VP
Abstract + Full Text Articles 2. Scientific Inputs
(Abs. + FT Article+ PPT)
2. New Product Proposal
(By M.A)
2. Investigator Initiated
Study (I I S)
2. Sales Team: New Joinee
(Refresher / Updates)
2. Internal Coaching for
Medical Affairs
2. BU Heads
Therapy Updates 3. Field Work Interaction 3.Clinical Trial Proposals 3. Survey &
Questionnaire
3. BD (Business
Development)
Prescribing Information
(Regulatory)
4. CME & Advisory Board
Meet
4. BA / BE Study 3. Self Development
(Behaviour & Personality)
4. PMT Team
Product Monograph 5. Query Resolution 5. Publication 5. Training Dept.
CME PPT 6. Digital Marketing
Scientific Input 7. Corporate Compliance
Query 8. HR
A.2 Medical Training 9. CRO/ Medical
Communication Agency
A.3 Promotional Material 10. Other
Medical Affairs: Till Date
A. New Product Launch B. Clinical Trials C. CME &
Ad. Board Meeting
D. Disease
Management Platform
E. Pharmacovigilance
Medical Affairs: Towards 2023

2. Diacar Oncos: April- Oct 2022
A. Medico Marketing Activity B. KOL Support and
Engagement
C. Long Term Growth Plan D. Clinical Trial E. Training and
Development
F. Medical Affairs
Training & Development
G. Corporate Meetings
A.1 New Product Launch/
Brand Promotion
Launch PPT
1. KOL Interactions – 16 1. New Product Evaluation
(BU / BD) - 3
1. Investigator Initiated
Study (I I S) – 2
1. Sales Team: New Joinee
(Refresher / Updates) - 25
1. Med. Affairs Daily Calls
(Mon – Wed – Fri) – 30
1. VP – 1
Abstract + Full Text Articles – 8 2. Scientific Inputs - 5
(Abs. + FT Article+ PPT)
2.Clinical Trial Proposals – 2 2. Survey &
Questionnaire – 2
2. Internal Coaching for
Medical Affairs – 1
2. BU Heads - 4
Therapy Updates – 9 3. Field Work Interaction
- 28
3. Self Development – 5
(Behaviour & Personality)
3. BD (Business
Development) – 1
Prescribing Information - 7
(Regulatory)
4. CME & Advisory Board
Meet – 13 (62)
4. PMT Team – 8
Product Monograph – 1 5. Query Resolution – 4 5. Training Dept. – 4
CME PPT - 5 6. Corporate Compliance – 1
Scientific Input – 7 7. CRO/ Medical – 4
Communication Agency
Query - 4
A.2 Medical Training – 2
A.3 Promotional Material – 1
Medical Affairs: Till Date
A. New Product
Launch
B. Clinical Trials C. CME &
Ad. Board Meeting
D. Disease Management
Platform
E. Pharmacovigilance
Linagliptin – April
2023
IITs on Glizid M in 100 patients across 5 centers to evaluate the beta cell function in T2DM – April 2023 (3
months + 6 months)
Expert Onco metting Mylogen forte: Diabetic Foot
workshop with GP/CP
ADR management for
Diacar & Oncos
Levothyroxine – April
2023
Real-world evidence in diabetes: relevance to clinical practice in patient with co-morbid condition with 500
HCP’s in 10000 patients – June 2023 (6 months + 1 years ) E2E
PRANA Question
PMS trial on Glizid M in 5000 patients at 250 HCP’s from April 2023 the duration of the study will be 5 years
Medical Affairs: Towards 2023